federal drug policy

Donald Trump is reportedly considering reclassifying marijuana from a Schedule I to a Schedule III controlled substance under the Controlled Substances Act, a shift that could have sweeping legal and economic consequences for the U.S. cannabis industry. According to The Guardian and The Wall Street Journal, the proposal—originally advanced but never finalized by the Biden…